Xeris Biopharma Holdings, Inc.

Healthcare · Biotechnology · United States

Last price 10.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.96B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patient...